PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 116 filers reported holding PMV PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,175,628 | +31.2% | 187,800 | 0.0% | 0.18% | +22.7% |
| Q1 2023 | $895,806 | -45.2% | 187,800 | 0.0% | 0.15% | -57.3% |
| Q4 2022 | $1,633,860 | -26.9% | 187,800 | 0.0% | 0.35% | +13.2% |
| Q3 2022 | $2,235,000 | -16.5% | 187,800 | 0.0% | 0.31% | +8.4% |
| Q2 2022 | $2,676,000 | -39.2% | 187,800 | -1.4% | 0.29% | -40.9% |
| Q4 2021 | $4,401,000 | -22.5% | 190,525 | 0.0% | 0.48% | +1.5% |
| Q3 2021 | $5,678,000 | +97.7% | 190,525 | +126.6% | 0.48% | +145.9% |
| Q2 2021 | $2,872,000 | +101.4% | 84,074 | +93.9% | 0.19% | +78.0% |
| Q1 2021 | $1,426,000 | – | 43,356 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |